Pharmaceutical Plastic Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Pharmaceutical Plastic Packaging Market Report is Segmented by Raw Material (Polypropylene [PP], Polyethylene Terephthalate [PET], Low-Density Polyethylene [LDPE], High-Density Polyethylene [HDPE], and Other Raw Materials), Product Type (Solid Containers, Dropper Bottles, Nasal Spray Bottles, Liquid Bottles, Oral Care, Pouches, Vials and Ampoules, Cartridges, Syringes, Caps and Closures, and Other Product Types), and Geography (North America [the United States and Canada], Europe [United Kingdom, Germany, France, Spain, Italy, and Rest of Europe], Asia-Pacific [China, India, Japan, and Rest of Asia-Pacific], Latin America [Brazil, Argentina, Mexico, and Rest of Latin America], and Middle East and Africa [United Arab Emirates, Saudi Arabia, South Africa, and Rest of Middle East and Africa]). The Market Sizes and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

Pharmaceutical Plastic Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Pharmaceutical Plastic Packaging Market Size

Pharmaceutical Plastic Packaging Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 55.24 Billion
Market Size (2030) USD 73.41 Billion
CAGR (2025 - 2030) 5.85 %
Fastest Growing Market Asia
Largest Market Asia
Market Concentration Low

Major Players

Pharmaceutical Plastic Packaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Pharmaceutical Plastic Packaging Market with other markets in Packaging Industry

Advanced Packaging

Packaging Equipment

Contract Packaging

Overall Packaging

Packaging Customers

Packaging Forms

Pharmaceutical Plastic Packaging Market Analysis

The Pharmaceutical Plastic Packaging Market size is estimated at USD 55.24 billion in 2025, and is expected to reach USD 73.41 billion by 2030, at a CAGR of 5.85% during the forecast period (2025-2030).

The pharmaceutical plastic packaging industry is experiencing significant transformation driven by increasing global healthcare expenditure and technological advancements in packaging solutions. The industry's landscape is being reshaped by stringent regulatory requirements that emphasize product safety and quality control measures. According to Evaluate, pharmaceutical research and development spending is projected to reach USD 285 billion by 2028, up from USD 238 billion in 2021, indicating substantial investment in new drug development that will require advanced pharmaceutical plastic solutions. This increased R&D spending is driving innovation in packaging materials and designs to ensure better product protection and longer shelf life.


Sustainability has emerged as a critical focus area for pharmaceutical plastic packaging manufacturers, with companies increasingly adopting eco-friendly materials and processes. Major industry players are developing recyclable and biodegradable packaging solutions while maintaining the necessary barrier properties and stability requirements for pharmaceutical products. The World Health Organization reports that approximately 3.5 billion people worldwide are affected by oral disorders, highlighting the massive scale of pharmaceutical packaging supplies needs across various medical conditions. This has led to increased emphasis on developing sustainable packaging solutions that can meet both environmental concerns and medical requirements.


The industry is witnessing significant consolidation through strategic partnerships and acquisitions to enhance manufacturing capabilities and geographic presence. In March 2023, ALPLA Pharma and Inden Pharma formed a joint venture to strengthen their market presence, with plans to produce 800 million pharmaceutical packaging items annually by 2023. Similarly, in January 2023, Amcor acquired Shanghai-based MDK, a leader in medical device packaging, demonstrating the industry's focus on expanding specialized packaging capabilities. These strategic moves are reshaping the competitive landscape and driving innovation in pharmaceutical plastic packaging solutions.


Manufacturing capacity expansion in emerging markets is becoming increasingly prevalent as companies seek to establish regional production hubs. For instance, in March 2023, Oliver Healthcare Packaging announced the opening of a new manufacturing facility in Malaysia, highlighting the industry's shift toward establishing a strong presence in high-growth regions. This trend is accompanied by the adoption of advanced manufacturing technologies and automation solutions to enhance production efficiency and maintain consistent quality standards. Companies are investing in smart packaging solutions that incorporate features like tamper-evidence, child-resistance, and improved barrier properties while focusing on cost-effectiveness and operational efficiency.

Segment Analysis: By Raw Material

Polyethylene Terephthalate (PET) Segment in Pharmaceutical Plastic Packaging Market

The Polyethylene Terephthalate (PET) segment dominates the pharmaceutical plastic packaging market, holding approximately 35% market share in 2024. PET has emerged as the preferred material choice due to its exceptional properties, including moisture resistance, high dimensional stability, and superior barrier characteristics. The material maintains a firm protective structure while exhibiting excellent moisture-resistant properties, making it particularly valuable for manufacturing pharmaceutical plastic bottles for liquids in the pharmaceutical industry. PET's natural CO2 barrier properties, combined with its ability to be easily blown into bottles or formed into sheets, have made it indispensable in pharmaceutical packaging plastics applications. The material's versatility is further enhanced by the possibility of incorporating colorants, UV blockers, oxygen barriers/scavengers, and other additives to develop products that match specific brand requirements. Additionally, PET's manufacturing process excludes heavy metals, eliminating concerns about harmful chemicals such as BPA or DEHP, which has further strengthened its position as the leading material choice in pharmaceutical packaging.

Market Analysis of Pharmaceutical Plastic Packaging Market: Chart for By Raw Material

High Density Polyethylene (HDPE) Segment in Pharmaceutical Plastic Packaging Market

The High Density Polyethylene (HDPE) segment is projected to experience the fastest growth rate of approximately 7% during the forecast period 2024-2029. HDPE's rapid growth is attributed to its excellent chemical resistance and high strength-to-weight ratio compared to common polymers, making it particularly suitable for pharmaceutical plastic packaging applications. The material's versatility in molding larger containers while maintaining lightweight properties has significantly contributed to its increasing adoption. HDPE's superior characteristics, including its ability to withstand harsh impacts and provide excellent protection against moisture, have made it increasingly popular for pharmaceutical packaging solutions. The material's growing popularity is further enhanced by its cost-effectiveness and ability to maintain product integrity across various environmental conditions. Recent innovations in HDPE pharmaceutical packaging, including enhanced barrier properties and improved recyclability features, are expected to further accelerate its adoption in the coming years.

Remaining Segments in Raw Material Segmentation

The remaining segments in the pharmaceutical plastic packaging market include Low Density Polyethylene (LDPE), Polypropylene (PP), and other materials, each serving specific applications in the industry. LDPE is particularly valued for its flexibility and chemical stability at room temperatures, making it ideal for applications requiring low-temperature flexibility and corrosion resistance. Polypropylene has gained significance due to its adaptability to injection molding processes and ability to create incredibly thin layers of plastic, particularly suitable for hinges on medication containers. Other materials, including polystyrene and polyvinyl chloride, continue to play niche roles in specific pharmaceutical packaging applications where their unique properties provide particular advantages. These segments collectively contribute to the diverse material options available to pharmaceutical manufacturers, enabling them to select the most appropriate packaging solution based on specific drug requirements and application needs.

Segment Analysis: By Product Type

Vials & Ampoules Segment in Pharmaceutical Plastic Packaging Market

The Vials and Ampoules segment dominates the pharmaceutical plastic packaging market, holding approximately 16% market share in 2024. This segment's prominence is driven by its crucial role in storing chemically unstable materials, medications, and chemicals while preventing tampering. The increasing demand for vials and ampoules is attributed to their superior moisture barrier properties, high dimensional stability, high impact strength, resistance to strain, minimal water absorption, transparency, and heat resistance capabilities. The segment's growth is particularly strong in densely populated regions, where pharmaceutical manufacturing is expanding rapidly. The rising consumption of biopharmaceuticals, vaccines, and insulin, especially in Asia-Pacific, Latin America, and Eastern Europe, has significantly boosted the adoption of plastic vials and ampoules.

Syringes Segment in Pharmaceutical Plastic Packaging Market

The Syringes segment is emerging as the fastest-growing category in the pharmaceutical plastic packaging market, projected to grow at approximately 7% during 2024-2029. This remarkable growth is driven by the rising population, proportional increase in aging demographics, and escalating prevalence of chronic diseases requiring injectable medications. The segment's expansion is further supported by rapid medical technology advancements and innovations by key industry players. Pre-fillable syringes have gained significant traction as they enable more precise drug administration while reducing needle exposure. The segment's growth is particularly pronounced in regions with expanding vaccination programs and increasing adoption of injectable medications for treating various chronic conditions.

Remaining Segments in Product Type Segmentation

The pharmaceutical plastic packaging market encompasses several other significant segments, including Liquid Bottles, Solid Containers, Caps & Closures, Dropper Bottles, Nasal Spray Bottles, Oral Care products, and Pouches. Liquid Bottles serve as essential packaging solutions for oral medications and syrups, while Solid Containers cater to tablet and capsule packaging needs. Caps & Closures play a crucial role in ensuring product safety and tamper-evidence. Dropper Bottles and Nasal Spray Bottles serve specialized delivery needs in the pharmaceutical sector. The Oral Care segment addresses specific requirements for dental and oral hygiene products, while Pouches offer flexible packaging solutions for various pharmaceutical applications. Each of these segments contributes uniquely to the market's diversity and meets specific pharmaceutical packaging requirements.

Pharmaceutical Plastic Packaging Market Geography Segment Analysis

Pharmaceutical Plastic Packaging Market in North America

The North American pharmaceutical plastic packaging market demonstrates robust growth driven by advanced healthcare infrastructure and increasing pharmaceutical consumption. The United States and Canada form the key markets in this region, with both countries showing significant developments in pharmaceutical manufacturing and packaging innovations. The region's market is characterized by stringent regulatory requirements, particularly from the FDA, which influence packaging material selection and design. Both countries are witnessing increased adoption of sustainable packaging solutions and investments in research and development for innovative pharmaceutical plastic packaging solutions.

Market Analysis of Pharmaceutical Plastic Packaging Market: Forecasted Growth Rate by Region

Pharmaceutical Plastic Packaging Market in United States

The United States dominates the North American market, holding approximately 83% market share in 2024. The country's pharmaceutical plastic packaging sector benefits from extensive pharmaceutical manufacturing capabilities and a well-established healthcare system. The market is driven by increasing prescription drug expenditure and growing demand for various packaging solutions, including bottles, containers, and blister packs. The presence of major pharmaceutical companies and packaging manufacturers, coupled with continuous technological advancements in packaging materials and designs, further strengthens the market position of the United States in the region.

Pharmaceutical Plastic Packaging Market in Canada

Canada emerges as the fastest-growing market in North America, with a projected growth rate of approximately 6% during 2024-2029. The country's pharmaceutical plastic packaging market is experiencing significant expansion driven by an increasing focus on product safety, regulatory requirements, and sustainability initiatives. The growing prevalence of chronic diseases and the subsequent rise in pharmaceutical production are creating new opportunities for packaging manufacturers. Canadian market players are increasingly investing in eco-friendly packaging solutions and advanced manufacturing technologies to meet evolving industry demands and environmental regulations.

Pharmaceutical Plastic Packaging Market in Europe

The European pharmaceutical plastic packaging market showcases significant diversity across its key markets, including the United Kingdom, Germany, France, Spain, and Italy. The region's market is characterized by a strong emphasis on sustainable packaging solutions and innovative technologies. European countries are witnessing increased adoption of recyclable materials and eco-friendly packaging designs, driven by stringent environmental regulations and growing consumer awareness. The market benefits from the presence of major pharmaceutical manufacturers and packaging companies, along with continuous investments in research and development.

Pharmaceutical Plastic Packaging Market in United Kingdom

The United Kingdom leads the European market, commanding approximately 17% market share in 2024. The country's pharmaceutical plastic packaging industry benefits from robust pharmaceutical manufacturing capabilities and significant research and development activities. The market is characterized by strict regulatory compliance requirements and a growing emphasis on sustainable packaging solutions. The presence of major pharmaceutical companies and packaging manufacturers, coupled with government initiatives supporting healthcare sector development, continues to drive market growth in the UK.

Pharmaceutical Plastic Packaging Market in Germany

Germany demonstrates the highest growth potential in Europe, with a projected growth rate of approximately 8% during 2024-2029. The country's market is driven by technological innovations and a strong focus on sustainable packaging solutions. German manufacturers are at the forefront of developing recyclable pharmaceutical packaging supplies and implementing advanced manufacturing processes. The presence of a robust pharmaceutical industry, coupled with increasing investments in healthcare infrastructure and research facilities, positions Germany as a key growth market in the region.

Pharmaceutical Plastic Packaging Market in Asia-Pacific

The Asia-Pacific region represents a dynamic market for pharmaceutical plastic packaging, encompassing diverse markets including China, India, and Japan. The region demonstrates strong growth potential driven by expanding pharmaceutical manufacturing capabilities, increasing healthcare investments, and a growing population. Each country in the region shows unique market characteristics, from China's large-scale manufacturing capabilities to India's growing pharmaceutical exports and Japan's advanced healthcare infrastructure.

Pharmaceutical Plastic Packaging Market in China

China dominates the Asia-Pacific pharmaceutical plastic packaging market, leveraging its extensive manufacturing capabilities and large pharmaceutical industry. The country's market benefits from significant government support for healthcare sector development and pharmaceutical manufacturing. The presence of numerous domestic and international packaging manufacturers, coupled with continuous technological advancements and increasing healthcare expenditure, strengthens China's position in the regional market.

Pharmaceutical Plastic Packaging Market in India

India emerges as the fastest-growing market in the Asia-Pacific region, driven by its expanding pharmaceutical manufacturing sector and increasing healthcare investments. The country's pharma plastic packaging industry benefits from growing domestic demand and rising pharmaceutical exports. Indian manufacturers are increasingly focusing on developing innovative packaging solutions and adopting sustainable practices to meet evolving market demands and regulatory requirements.

Pharmaceutical Plastic Packaging Market in Latin America

The Latin American pharmaceutical plastic packaging market encompasses key countries including Brazil, Argentina, and Mexico, each contributing significantly to regional growth. The market is characterized by increasing investments in pharmaceutical manufacturing capabilities and growing healthcare awareness. Brazil emerges as the largest market in the region, while Argentina demonstrates the fastest growth potential. The region's market is driven by expanding healthcare infrastructure, rising pharmaceutical production, and increasing adoption of modern packaging solutions.

Pharmaceutical Plastic Packaging Market in Middle East & Africa

The Middle East & Africa pharmaceutical plastic packaging market shows promising growth potential driven by increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. The region benefits from growing healthcare awareness and improving medical infrastructure. The market is characterized by increasing adoption of modern packaging solutions and a rising focus on quality standards. The region's pharmaceutical packaging industry is witnessing significant developments in terms of manufacturing capabilities and technological advancements, particularly in countries with strong healthcare systems.

Pharmaceutical Plastic Packaging Industry Overview

Top Companies in Pharmaceutical Plastic Packaging Market

The pharmaceutical plastic packaging market is characterized by the presence of established players like Gerresheimer AG, Amcor PLC, Berry Plastics Group, Aptar Group, and West Pharmaceutical Services, leading the industry through continuous innovation and strategic expansion. Companies are focusing on developing sustainable packaging solutions, including recyclable materials and eco-friendly alternatives, to meet growing environmental concerns. The industry witnesses significant investment in research and development to create advanced packaging solutions that ensure drug stability and safety while complying with stringent regulatory requirements. Market leaders are expanding their global footprint through strategic acquisitions, partnerships, and facility expansions, particularly in emerging markets. The emphasis on technological advancement is evident in the development of smart packaging solutions, child-resistant closures, and innovative delivery systems that enhance patient compliance and product protection.

Global Leaders Dominate Through Strategic Integration

The pharmaceutical plastic packaging market exhibits a moderately consolidated structure, with major global players controlling a significant portion of the market through their extensive product portfolios and manufacturing capabilities. These industry leaders have established strong vertical integration across the value chain, from raw material procurement to final product distribution, enabling them to maintain quality control and operational efficiency. The market is characterized by a mix of large multinational corporations and specialized regional players, with the former leveraging their research capabilities and global presence to maintain market leadership.


The industry has witnessed considerable merger and acquisition activity, as companies seek to expand their geographical presence, enhance technological capabilities, and strengthen their product offerings. Major players are actively pursuing strategic partnerships with pharmaceutical companies and technology providers to develop innovative packaging solutions. Regional players are increasingly becoming attractive acquisition targets for global companies looking to establish a stronger presence in emerging markets and access local distribution networks. This consolidation trend is expected to continue as companies strive to achieve economies of scale and expand their market reach.

Innovation and Sustainability Drive Future Success

Success in the pharmaceutical plastic packaging market increasingly depends on companies' ability to develop sustainable packaging solutions while maintaining product safety and compliance with regulatory requirements. Market incumbents are investing heavily in research and development to create innovative packaging solutions that address both environmental concerns and customer needs. Companies are focusing on developing recyclable materials, reducing packaging waste, and implementing circular economy principles in their operations. The ability to offer comprehensive packaging solutions, including customization options and technical support services, has become crucial for maintaining market position.


For new entrants and smaller players, success lies in identifying and serving niche market segments with specialized packaging solutions. Companies must focus on building strong relationships with pharmaceutical manufacturers and developing expertise in specific packaging applications or regional markets. The increasing focus on patient safety and drug stability creates opportunities for companies that can develop innovative solutions for sensitive drug formulations. Additionally, the growing trend toward personalized medicine and biologics presents opportunities for specialized packaging solutions. Companies must also prepare for potential regulatory changes regarding plastic usage and environmental protection, which could significantly impact market dynamics and competitive positioning. Furthermore, becoming a flexible packaging supplier for pharma can offer a competitive edge in this evolving landscape.

Pharmaceutical Plastic Packaging Market Leaders

  1. Gerresheimer AG

  2. Berry Global Inc.

  3. Aptar Group Inc.

  4. West Pharmaceutical Services, Inc.

  5. Comar LLC

  6. *Disclaimer: Major Players sorted in no particular order
Pharmaceutical Plastic Packaging Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Pharmaceutical Plastic Packaging Market News

  • January 2024: Savillex, a container and containment solutions provider, has unveiled its latest product line under the Purillex brand PETG Square Media Bottles. These bottles are designed for critical life sciences applications and are produced in Savillex's ISO Class 7 facility in the United States.
  • January 2024: Tekni-Plex Inc. introduced the world’s first 30% post-consumer recycled content pharmaceutical-grade blister film along with the partnership with Alpek Polyester. The blister film is also fully recyclable and meets all pharmaceutical requirements for PET as outlined in the European Pharmacopoeia Section 3.1.15 and the United States Pharmacopoeia Section 661.1.

Pharmaceutical Plastic Packaging Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of the Impact of Geopolitical Scenario on the Industry

5. MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Rigid and Flexible Pharmaceutical Plastic Products
    • 5.1.2 Development of Better and More Advanced Healthcare Infrastructure
  • 5.2 Market Restraints
    • 5.2.1 Regulations Restricting the Sales and Availability of Pharmaceutical Plastic Products
    • 5.2.2 Fluctuations in Raw Material Cost

6. MARKET SEGMENTATION

  • 6.1 By Raw Material
    • 6.1.1 Polypropylene (PP)
    • 6.1.2 Polyethylene Terephthalate (PET)
    • 6.1.3 Low Density Polyethylene (LDPE)
    • 6.1.4 High Density Polyethylene (HDPE)
    • 6.1.5 Other Raw Materials
  • 6.2 By Product Type
    • 6.2.1 Solid Containers
    • 6.2.2 Dropper Bottles
    • 6.2.3 Nasal Spray Bottles
    • 6.2.4 Liquid Bottles
    • 6.2.5 Oral Care
    • 6.2.6 Pouches
    • 6.2.7 Vials and Ampoules
    • 6.2.8 Cartridges
    • 6.2.9 Syringes
    • 6.2.10 Caps and Closures
    • 6.2.11 Other Product Types
  • 6.3 By Geography***
    • 6.3.1 North America
    • 6.3.1.1 United States
    • 6.3.1.2 Canada
    • 6.3.2 Europe
    • 6.3.2.1 United Kingdom
    • 6.3.2.2 Germany
    • 6.3.2.3 France
    • 6.3.2.4 Spain
    • 6.3.2.5 Italy
    • 6.3.3 Asia
    • 6.3.3.1 China
    • 6.3.3.2 India
    • 6.3.3.3 Japan
    • 6.3.3.4 Australia and New Zealand
    • 6.3.4 Latin America
    • 6.3.4.1 Brazil
    • 6.3.4.2 Argentina
    • 6.3.4.3 Mexico
    • 6.3.5 Middle East and Africa
    • 6.3.5.1 United Arab Emirates
    • 6.3.5.2 Saudi Arabia
    • 6.3.5.3 South Africa

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles*
    • 7.1.1 Gerresheimer AG
    • 7.1.2 Amcor Group GmbH
    • 7.1.3 Berry Global Inc.
    • 7.1.4 Aptar Group Inc.
    • 7.1.5 O.Berk Company LLC
    • 7.1.6 Pretium Packaging LLC
    • 7.1.7 Klockner Pentaplast Group
    • 7.1.8 Comar LLC
    • 7.1.9 Gil Pack Group
    • 7.1.10 Drug Plastics & Glass Company Inc.
    • 7.1.11 West Pharmaceutical Services Inc.

8. INVESTMENT ANALYSIS

9. FUTURE OF THE MARKET

**Subject to Availability
***In the final report, Asia, Australia, and New Zealand will be studied together as 'Asia Pacific'. Other European Countries will be studied together as 'Rest of Europe', Other Asian Countries will be studied together as 'Rest of Asia Pacific', Other Latin American Countries will be studied together as ' Rest of Latin America', and Other Middle East and African Countries will be studied together as ' Rest of Middle East and Africa'.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Pharmaceutical Plastic Packaging Industry Overview

Pharmaceutical plastic packaging involves using plastic materials to package pharmaceutical drugs. Pharmaceutical plastic bottles, tailored for storing and distributing pharmaceutical products, are pivotal in upholding the safety, efficacy, and integrity of medications and pharmaceutical items. Pharmaceutical plastic packaging products are designed to protect the contents from contamination, moisture, and light, ensuring the drugs remain effective throughout their shelf life. Additionally, plastic packaging offers lightweight, durability, and cost-effectiveness benefits, making it a preferred choice in the pharmaceutical industry.

The pharmaceutical plastic packaging market is segmented by raw material (polypropylene (PP), polyethylene terephthalate (PET), low-density polyethylene (LDPE), high-density polyethylene (HDPE), and other raw materials), product type (solid containers, dropper bottles, nasal spray bottles, liquid bottles, oral care, pouches, vials, and ampoules, cartridges, syringes, caps and closures, and other product types), and geography (North America (the United States and Canada), Europe (United Kingdom, Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, and Rest of Asia Pacific), Latin America (Brazil, Argentina, Mexico, and Rest of Latin America), and Middle East and Africa (United Arab Emirates, Saudi Arabia, South Africa, and Rest of Middle East and Africa)). The report offers market forecasts and size in value (USD) for all the above segments.

By Raw Material Polypropylene (PP)
Polyethylene Terephthalate (PET)
Low Density Polyethylene (LDPE)
High Density Polyethylene (HDPE)
Other Raw Materials
By Product Type Solid Containers
Dropper Bottles
Nasal Spray Bottles
Liquid Bottles
Oral Care
Pouches
Vials and Ampoules
Cartridges
Syringes
Caps and Closures
Other Product Types
By Geography*** North America United States
Canada
Europe United Kingdom
Germany
France
Spain
Italy
Asia China
India
Japan
Australia and New Zealand
Latin America Brazil
Argentina
Mexico
Middle East and Africa United Arab Emirates
Saudi Arabia
South Africa
Need A Different Region or Segment?
Customize Now

Pharmaceutical Plastic Packaging Market Research FAQs

How big is the Pharmaceutical Plastic Packaging Market?

The Pharmaceutical Plastic Packaging Market size is expected to reach USD 55.24 billion in 2025 and grow at a CAGR of 5.85% to reach USD 73.41 billion by 2030.

What is the current Pharmaceutical Plastic Packaging Market size?

In 2025, the Pharmaceutical Plastic Packaging Market size is expected to reach USD 55.24 billion.

Who are the key players in Pharmaceutical Plastic Packaging Market?

Gerresheimer AG, Berry Global Inc., Aptar Group Inc., West Pharmaceutical Services, Inc. and Comar LLC are the major companies operating in the Pharmaceutical Plastic Packaging Market.

Which is the fastest growing region in Pharmaceutical Plastic Packaging Market?

Asia is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Pharmaceutical Plastic Packaging Market?

In 2025, the Asia accounts for the largest market share in Pharmaceutical Plastic Packaging Market.

What years does this Pharmaceutical Plastic Packaging Market cover, and what was the market size in 2024?

In 2024, the Pharmaceutical Plastic Packaging Market size was estimated at USD 52.01 billion. The report covers the Pharmaceutical Plastic Packaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Pharmaceutical Plastic Packaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Pharmaceutical Plastic Packaging Market Research

Mordor Intelligence provides comprehensive insights into the pharmaceutical plastic packaging market. We leverage our extensive experience in analyzing plastics for the pharmaceutical industry. Our expert analysts offer a detailed examination of pharmaceutical packaging supplies and trends. This includes insights into pharmaceutical plastic bottles manufacturers and the dynamics of flexible packaging supplier for pharma. The report covers crucial aspects of biopharma plastics applications, polymers for pharmaceutical packaging, and innovative plastic solutions for the pharmaceutical industry. It is available as an easy-to-download report PDF.

Stakeholders across the value chain, from pharmaceutical containers suppliers to end-users, benefit from our detailed analysis of plastic healthcare packaging market developments. The report examines various plastic packaging material pharmaceutical industry segments, offering insights into plastics for biopharma applications and emerging technologies. Our research encompasses pharmaceutical plastic packaging trends, manufacturing processes, and regulatory frameworks. This provides actionable intelligence for businesses seeking to optimize their plastic solutions for the pharmaceutical industry. The comprehensive analysis helps stakeholders make informed decisions while navigating the evolving landscape of pharmaceutical packaging plastics.